StockData
Sangamo Therapeutics, Inc logo

Sangamo Therapeutics, Inc (SGMOQ) stock

SGMOQOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 4/30
$0.10−0.01 (-8.17%)

Close on Oct 19, 2026Market cap $39.43MP/E –Yield –

Sangamo Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Sangamo Therapeutics's price to sales ratio was 0.9× on Oct 19, 2026, against 1.7× a year earlier. Over the last 5 years it ranged from 0.4× to 25.6×, with a median of 3.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.9×−2.2
2025Dec 31, 20253.2×−0.6
2024Dec 31, 20243.8×+3.3
2023Dec 29, 20230.5×−3.7
2022Dec 30, 20224.2×−5.7
2021Dec 31, 20219.9×−3.7
2020Dec 31, 202013.6×+1.3
2019Dec 31, 201912.2×−4.3
2018Dec 31, 201816.5×−26.0
2017Dec 29, 201742.6×+31.6
2016Dec 30, 201611.0×−3.1
2015Dec 31, 201514.1×−13.4
2014Dec 31, 201427.5×−5.1
2013Dec 31, 201332.6×+14.4
2012Dec 31, 201218.2×+3.7
2011Dec 30, 201114.5×–

More Sangamo Therapeutics figures

See a number that looks wrong?